Amicus Therapeutics (FOLD) - Stock price history

Stock price history of Amicus Therapeutics from 2007 to 2025

Annual Stock Price Performance

Year	Performance
2025	52.31%
2024	-33.85%
2023	18.94%
2022	0.83%
2021	-46.97%
2020	141.78%
2019	-2.99%
2018	-36.81%
2017	180.51%
2016	-44.96%
2015	12.66%
2014	245.23%
2013	-17.25%
2012	-24.93%
2011	-24.56%
2010	22.40%
2009	-50.37%
2008	-22.82%
2007	-25.50%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Biogen BIIB	A$264.28	2.88%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$92.45	17.71%	🇺🇸 USA
Esperion Therapeutics ESPR	A$5.94	3.42%	🇺🇸 USA
GlaxoSmithKline GSK	A$73.49	0.66%	🇬🇧 UK
Lexicon Pharmaceuticals LXRX	A$1.77	-0.85%	🇺🇸 USA
Novo Nordisk NVO	A$72.71	1.01%	🇩🇰 Denmark

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Amicus Therapeutics (FOLD)